Get the Stockscreener App
0.6963
0.10%
-0.0007
After Hours:
.69
-0.0063
-0.90%
Myomo Inc stock is traded at $0.6963, with a volume of 228.13K.
It is down -0.10% in the last 24 hours and down -7.23% over the past month.
Myomo, Inc., a commercial stage medical robotics company, designs, develops, and produces myoelectric braces or orthotics for people suffering with neuromuscular disorders in the United States. It offers MyoPro, a powered upper limb orthosis that supports the arm, as well as restores function to the weakened or paralyzed arms of patients suffering from CVA stroke, brachial plexus injury, traumatic brain injury, spinal cord injury, ALS, or other neuromuscular disease or injury. The company serves orthotics and prosthetics practices or clinics, as well as the veteran administration and other hospitals through orthotics and prosthetics providers, and distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Cambridge, Massachusetts.
See More
Previous Close:
$0.697
Open:
$0.69
24h Volume:
228.13K
Relative Volume:
0.47
Market Cap:
$26.82M
Revenue:
$40.93M
Net Income/Loss:
$-15.57M
P/E Ratio:
-1.8703
EPS:
-0.3723
Net Cash Flow:
$-17.84M
1W Performance:
-3.95%
1M Performance:
-7.23%
6M Performance:
-23.48%
1Y Performance:
-87.01%
1-Day Range:
$0.69
$0.72
1-Week Range:
$0.6869
$0.74
52-Week Range:
$0.626
$5.39
Myomo Inc Stock (MYO) Company Profile
Name
Myomo Inc
Sector
Industry
Phone
617-996-9058
Address
One Broadway, 14th Floor, Cambridge, MA
Compare MYO vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MYO
Myomo Inc
|
0.6963 | 26.84M | 40.93M | -15.57M | -17.84M | -0.3723 |
ABT
Abbott Laboratories
|
104.83 | 180.82B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
327.65 | 125.72B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
87.89 | 111.16B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
69.78 | 101.28B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
82.67 | 47.45B | 6.07B | 1.06B | 1.34B | 1.8063 |
Myomo Inc Stock (MYO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-31-24 | Initiated | Craig Hallum | Buy |
| May-20-24 | Initiated | Lake Street | Buy |
| Dec-15-23 | Initiated | H.C. Wainwright | Buy |
| Nov-11-20 | Upgrade | ROTH Capital | Neutral → Buy |
| May-27-20 | Initiated | Dougherty & Company | Buy |
| Oct-02-17 | Initiated | H.C. Wainwright | Buy |
View All
Myomo Inc Stock (MYO) Latest News
If You Invested $1,000 in Myomo (MYO) - Stock Titan
EPS Watch: Is Myomo Inc a potential multi baggerMarket Trend Review & Technical Pattern Recognition Alerts - baoquankhu1.vn
MYO Stock Price, Quote & Chart | MYOMO INC (NYSEARCA:MYO) - ChartMill
Getz Heather C, director at Myomo, buys $13,972 in stock - Investing.com
Getz Heather C, director at Myomo, buys $13,972 in stock By Investing.com - Investing.com India
Myomo (MYO) director Heather Getz purchases 20,000 common shares - Stock Titan
Myomo, Inc. (MYO) Reports Q2 Loss, Tops Revenue Estimates - MSN
2026 Week #11: Where “Exoskeleton” Came From, Myomo Expands Coverage, Exo Games Return - Exoskeleton Report
Kirk Thomas F buys Myomo (MYO) shares worth $51,112 By Investing.com - Investing.com South Africa
Kirk Thomas F buys Myomo (MYO) shares worth $51,112 - Investing.com
Myomo (MYO) director adds 72,000 MYO shares in open-market purchase - Stock Titan
Elevance Expands Myomo Coverage And Broadens Technology Enabled Care Story - Sahm
MYOMO (MYO) director boosts stake with 70,000-share open-market buy - Stock Titan
Elevance Expands Myomo Coverage To Support Tech Enabled Care Narrative - Yahoo Finance
Myomo price target lowered to $3 from $4 at Alliance Global - TipRanks
Analysts Offer Insights on Healthcare Companies: Definitive Healthcare Corp (DH), Myomo (MYO) and OS Therapies Incorporated (OSTX) - The Globe and Mail
Myomo Inc. Flags High Risk in Forward-Looking Statements, Urges Caution on Reimbursement, Financing and Growth Plans - The Globe and Mail
Myomo Inc (MYO) Q4 2025 Earnings Call Highlights: Record Revenue - GuruFocus
Craig-Hallum Maintains Buy on Myomo, Inc. (MYO) March 2026 - Meyka
Craig-Hallum cuts Myomo stock price target to $1.10 on guidance miss - Investing.com Australia
Myomo enters network agreement with Elevance Health plans - Investing.com Australia
Analysts Offer Insights on Healthcare Companies: Dianthus Therapeutics (DNTH), Myomo (MYO) and Hims & Hers Health (HIMS) - The Globe and Mail
Myomo, Inc. 2026 Annual Report: Market Leadership, Competitive Risks, and Myoelectric Orthotics Business Overview - Minichart
Myomo’s operating loss hits USD 2.8M in Q4 2025 - Medical Buyer
MYO Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
12 Health Care Stocks Moving In Monday's After-Market Session - Sahm
Myomo Q4 2025 Earnings Call Transcript - MarketBeat
Myomo, Inc. (MYO) Reports Q4 Loss, Tops Revenue Estimates - Bitget
Myomo Reports Fourth Quarter and Full Year 2025 Financial and Operating Results - 01net
Myomo earnings missed, revenue topped estimates By Investing.com - Investing.com Canada
Myomo reports Q4 EPS (9c), consensus (9c) - TipRanks
MYO Posts Strong Q4 Revenue Surpassing Expectations - GuruFocus
Myomo (MYO) Projects Lower Q1 Revenue Amid Market Expectations - GuruFocus
Myomo sees FY26 revenue $43M-$46M, consensus $46.97M - TipRanks
Myomo, Elevance agree to contract for multi-state network participation - TipRanks
Elevance Health (ELV) Partners with Myomo to Expand Access to My - GuruFocus
Myomo, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Myomo Q4 revenue falls on lower average selling price - TradingView
Myomo (NYSE: MYO) grows 2025 revenue 26% but posts larger annual loss - Stock Titan
Earnings Breakdown: Myomo Q4 - Benzinga
BRIEF-Myomo Q4 EPS USD -0.09 - TradingView
Press Release: Myomo Reports Fourth Quarter and Full Year 2025 Financial and Operating Results - 富途牛牛
Myomo and Elevance Health Agree to Contract for Multi-State Network Participation - Business Wire
Gains Recap: Can Myomo Inc sustain earnings growth2025 Growth vs Value & Fast Entry Momentum Alerts - baoquankhu1.vn
Myomo to Announce Q4 Earnings on March 9 - Intellectia AI
Myomo (MYO) Set to Release Q4 Earnings with High Expectations - GuruFocus
Market Fear: Is Myomo Inc a potential multi bagger2025 Risk Factors & Fast Gain Swing Alerts - baoquankhu1.vn
Preview: Myomo's Earnings - Benzinga
MYO Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Aug Sectors: Will Myomo Inc benefit from geopolitical trendsJuly 2025 Market Mood & Risk Managed Investment Signals - baoquankhu1.vn
Myomo to Report Fourth Quarter 2025 Financial Results on March 9 - 01net
Myomo Inc Stock (MYO) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):